Search Results

You are looking at 291 - 300 of 1,224 items for :

  • Refine by Access: All x
Clear All
Full access

Karen Hock and Cari Utendorf

measures with a tape measure and bioimpedance spectroscopy. The patients are referred from their surgical oncologist before surgery and after surgery. Patients are followed for lymphedema surveillance for the first two years following surgery at set time

Full access

Yunyun Liu, KKL Chan, and Hui Zhou

Purpose : Neoadjuvant chemotherapy (NACT) can reduce tumor burden, lower difficulty of surgery in advanced ovarian cancer. However, the option of NACT cycle is still highly controversial. This paper intends to explore whether the number of NACT

Full access

J. Sybil Biermann

-speed burr is preferred in this relatively younger age group over more extensive surgery requiring skeletal reconstruction ( Figure 1 ). The challenge with surgery is to remove as much tumor as possible while leaving the joint intact, she added. However

Full access

Robert J. Morgan Jr.

centimeter residual disease at the completion of the surgery. However, the NCCN Guidelines now state that “maximal effort should be made to remove all gross disease.” Another example is how systemic chemotherapy recommendations have evolved after studies

Full access

Jaffer A. Ajani

Esophageal cancer (EC) is a difficult disease to treat, even when it is localized. For localized EC (LEC), chemoradiation followed by surgery (trimodality), for patients who can withstand surgery, is the preferred therapy over preoperative

Full access

Youmna Ashraf Sherif, Sukriti Bansal, Rachel W. Davis, Marcia Barnett, Umang M. Parikh, Hunter Bechtold, Hudson Holmes, Ahmad N. Elhajj, Jed G. Nuchtern, Chad T. Wilson, and Cary Hsu

Objective: The COVID-19 pandemic has had an unprecedented impact on healthcare delivery systems. Surgery, anesthesia, emergency, and intensive care services have been heavily affected by the pandemic. Multiple national surgical organizations in the

Full access

Urmeel Patel, Nicole Hook, Meenakshi Malhotra, Perry Olshan, Paul R. Billings, Alexey Aleshin, and Angel Rodriguez

(ctDNA) analysis using assay Signature®, (bespoke mPCR NGS assay) to identify molecular residual disease and treatment response. Results: The patient achieved partial response to ddAC but eventually progressed after paclitaxel. Pathological reports post-surgery

Full access

Ana Ribeiro, César Alvarez, Isabel Armas, Nuno Teixeira, Tatiana Santos, Carla Freitas, and João Barros da Silva

laparoscopy. The aim of this study was to compare laparoscopic and open gastrectomy in the treatment of this cancer, with emphasis on the number of lymphatic nodes harvested. METHODS : Retrospective analysis of patients submitted to surgery for gastric cancer

Full access

Eric Chen, Todd Aquino-Michaels, Sadhvi Batra, Riley Lochner, Anthony Rizzo, Ravi Kyasaram, Eleanor Harris, Tiffany Hodges, Lindsay Ferguson, and Serah Choi

underwent surgery with post-operative RT and 41 received radiation alone, with no significant difference in type of RT delivered between groups. The median OS for those with and without surgery was 6.6 vs. 3.5 months, respectively (p=.05). The median size of

Full access

Barbara S Schwartzberg, A. M. Nisar Syed, and Craig Wengler

Purpose : Obese women with breast cancer have more treatment complications linked to surgery, radiation, and chemotherapy, and are at increased risk for local recurrence. 40% of obese (BMI of at least 30) patients (pts) who choose breast